Regenerative medicine with stem cells holds great hope for the treatment of degenerative disease. The medical potential of embryonic stem cells remains relatively untapped at this point, and significant scientific hurdles remain to be overcome before these cells might be considered safe and effective for uses in patients. Meanwhile, adult stem cells have begun to show significant capabilities of their own in repair of damaged tissues, in both animal models and early patient trials.
MartinGR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A1981;78:7634–8.
2.
EvansMJ, KaufmanMH. Establishment in culture of pluripotential cells from mouse embryos. Nature1981;292:154–6.
3.
ThomsonJA, Itskovitz-EldorJ, ShapiroSS, . Embryonic stem cell lines derived from human blastocysts. Science1998;282:1145–7.
4.
ShamblottMJ, AxelmanJ, WangS, . Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci U S A1998;95:13726–31.
KeirsteadH, NistorG, BernalG, . Human embryonic stem cell derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci2006;25:4694–705.
7.
NistorGI, TotoiuM, HaqueN, . Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia2006;49:385–96.
8.
TakagiY, TakahashiJ, SaikiH, . Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest2006;115:102–9.
9.
Ben-HurT, IdelsonM, KhanerH, . Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinson's rats. Stem Cells2004;22:1246–55.
10.
NishimuraF, YoshikawaM, KandaS, . Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. Stem Cells2003;21:171–80.
11.
BjorklundLM, Sanchez-PernauteR, ChangS, . Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A2002;99:2344–9.
12.
WakitaniS, TakoakaK, HattoriT, . Embryonic stem cells injected into the mouse knee joint form teratomas and subsequently destroy the joint. Rheumatology2003;42:162–5.
13.
SipioneS, EshpeterA, LyonJG, . Insulin expressing cells from differentiated embryonic stem cells are not beta cells. Diabetologia2004;47:499–508.
14.
HodgsonDM, BehfarA, ZingmanLV, . Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol2004;287:471–9.
15.
MinJY, YangY, SullivanMF, . Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg2003;125:361–9.
HoriY, RulifsonIC, TsaiBC, . Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci U S A2002;99:16105–10.
18.
LumelskyN, BlondelO, LaengP, . Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science2001;292:1389–94.
RajagopalJ, AndersonWJ, KumeS, . Insulin staining of ES cell progeny from insulin uptake. Science2003;299:299–299.
21.
OdoricoJS, KaufmanDS, ThomsonJA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells2001;19:193–204.
22.
ZwakaTP, ThomsonJA. Homologous recombination in human embryonic stem cells. Nat Biotechnol2003;21:319–21.
23.
SpitzerTR, DelmonicoF, Tolkoff-RubinN, . Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation1999;68:480–4.
24.
HwangWS, RohSI, LeeBC, . Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science2006;308:1777–83.
25.
MombaertsP. Therapeutic cloning in the mouse. Proc Natl Acad Sci U S A2003;100:11924–5.
26.
TrounsonAO. The derivation and potential use of human embryonic stem cells. Reprod Fertil Dev2001;13:523–32.
27.
RideoutWM, HochedlingerK, KybaM, . Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell2002;109:17–27.
28.
TsaiRYL, KittappaR, McKayRDG. Plasticity, niches, and the use of stem cells. Dev Cell2002;02:707–12.
LanzaR, MooreMAS, WakayamaT, . Regeneration of the infarcted heart with stem cells derived by nuclear transplantation. Circ Res2004;94:820–7.
31.
LanzaR, ChungHY, YooJJ, . Generation of histocompatible tissue using nuclear transplantation. Nat Biotechnol2002;20:689–96.
32.
PrenticeD.Adult stem cells. In: Monitoring stem cell research: a report of the President's Council on Bioethics. Washington (DC): Government Printing Office; 2004. p.309–46.
33.
KrauseDS, TheiseND, CollectorMI, . Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell2001;105:369–77.
34.
JiangY, JahagirdarBN, ReinhardtRL, . Pluripotency of mesenchymal stem cells derived from adult marrow. Nature2002;418:41–9.
35.
D'IppolitoG, DiabiraS, HowardGA, . Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci2004;117:2971–81.
36.
YoonY-S, WeckerA, HeydL, . Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest2006;115:326–38.
37.
ZhaoY, GlesneD, HubermanE. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A2003;100:2426–31.
38.
LiH, LiuH, HellerS. Pluripotent stem cells from the adult mouse inner ear. Nat Med2003;09:1293–9.
39.
KöglerG, SenskenS, AireyJA, . A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med2004;200:123–35.
40.
McGuckinCP, ForrazN, BaradezN-O, . Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif2006;38:245–55.
41.
MurrellW, FeronF, WetzigA, . Multipotent stem cells from adult olfactory mucosa. Dev Dyn2006;233:496–515.
42.
PrusaA-R, MartonE, RosnerM, . Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?. Hum Reprod2003;18:1489–93.
ShyuW-C, LinS-Z, YangH-I, . Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation2004;110:1847–54.
45.
WillingAE, VendrameM, MalleryJ, . Mobilized peripheral blood stem cells administered intravenously produce functional recovery in stroke. Cell Transplant2003;12:449–54.
46.
ReissP, ZhangC, SaatmanKE, . Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury. Neurosurgery2002;51:1043–52.
47.
HeissigB, HattoriK, DiasS, . Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell2002;109:625–37.
48.
LuJ, FeronF, Mackay-SimA, . Olfactory ensheathing cells promote locomotor recovery after delayed transplantation into transected spinal cord. Brain2002;125:14–21.
49.
HofstetterCP, SchwarzEJ, HessD, . Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A2002;99:2199–204.
50.
OhtaM, SuzukiY, NodaT, . Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol2004;187:266–78.
51.
HofstetterCP, HolmstromNAV, LiljaJA, . Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentitation improves outcome. Nat Neurosci2006;08:346–53.
52.
SteevesJ, FawcettJ, TuszynskiM. Report of International Clinical Trials Workshop on Spinal Cord Injury. Spinal Cord2004;42:591–7.
53.
DezawaM, KannoH, HoshinoM, . Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest2004;113:1701–10.
54.
LikerMA, PetzingerGM, NixonK, . Human neural stem cell transplantation in the MPTP-lesioned mouse. Brain Res2003;971:168–77.
55.
LévesqueM, NeumanT. Autologous transplantation of adult human neural stem cells and differentiated dopaminergic neurons for Parkinson disease: 1-year postoperative clinical and functional metabolic result [abstract]. American Association of Neurological Surgeons Annual Meeting, April 3, 2002. Available at: http://www.aans.org/Library/Article.aspx?ArticleId=12096 (accessed December 8, 2005).
56.
GillSS, PatelNK, HottonGR, . Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med2003;09:589–95.
57.
LoveS, PlahaP, PatelNK, . Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain. Nat Med2006;11:703–4.
58.
OtaniA, DorrellMI, KinderK, . Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineage-negative hematopoietic stem cells. J Clin Invest2004;114:765–74.
59.
OtaniA, KinderK, EwaltK, . Bone marrow derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat Med2002;08:1004–10.
60.
TomitaM, YamadaH, AdachiY, . Bone marrow derived stem cells can differentiate into retinal cells in injured rat retina. Stem Cells2004;20:279–83.
61.
SapirT, ShternhallK, Meivar-LevyI, . Cell-replacement therapy for diabetes: generating functional insulin-producing tissue from adult human liver cells. Proc Natl Acad Sci U S A2006;102:7964–9.
62.
OhS-H, MuzzonigraTM, BaeS-H, . Adult bone marrow-derived cells transdifferentiating into insulin-producing cells for the treatment of type I diabetes. Lab Invest2004;84:607–17.
63.
IanusA, HolzGG, TheiseND, . In vivo derivation of glucose competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest2003;111:843–50.
64.
SeabergBM, SmuklerSR, KiefferTJ, . Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol2004;22:1115–24.
KreiselW, PotthoffK, BertzH, . Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation. Bone Marrow Transplant2003;32:337–40.
70.
EscolarML, PoeMD, ProvenzaleJM, . Transplantation of umbilical cord-blood in babies with infantile Krabbe's disease. N Engl J Med2006;352:2069–81.
71.
LendeckelS, JodickeA, ChristophisP, . Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. J Craniomaxillofac Surg2004;32:370–3.
72.
BrittenMB, AbomaaliND, AssmusB, . Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction. Circulation2003;108:2212–8.
73.
WollertKC, MeyerGP, LotzJ, . Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet2004;364:141–8.
74.
DohmannHFR, PerinEC, TakiyaCM, . Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure. Circulation2006;112:521–6.
